Cutting-Edge Strategies in Drug Delivery and Immunotherapy for Autoimmune Disorders (eBook)
284 Seiten
Springer (Verlag)
978-981-95-0520-3 (ISBN)
Autoimmune diseases represent a significant and complex global health burden, particularly among women, yet their underlying causes remain only partially understood. Affecting nearly every organ system, these conditions are driven by intricate interactions between genetic susceptibility, epigenetic modifications, and environmental triggers such as viral infections and toxins. With over 80 distinct autoimmune disorders identified—ranging from systemic to organ-specific—diagnosis and treatment continue to pose substantial clinical challenges. Despite progress in identifying autoantibodies and disease mechanisms, current therapies fall short of inducing long-term immune tolerance or preventing disease progression. This book offers a comprehensive exploration of the latest research into the molecular, genetic, and cellular underpinnings of autoimmune disease pathogenesis. It presents emerging therapeutic approaches grounded in advanced computational modeling, systems biology, and bioinformatics, as well as the design of novel bioactive compounds. A particular focus is placed on next-generation, nanoparticle-based drug delivery systems that promise to transform the treatment landscape by enhancing targeting specificity and minimizing systemic side effects. With in-depth coverage of Rheumatoid Arthritis (RA), Type 1 Diabetes (T1D), and Multiple Sclerosis (MS), this volume serves as a critical resource for specialists, researchers, and clinicians seeking to deepen their understanding of autoimmune disease mechanisms and therapeutic innovation. Through interdisciplinary insights and a forward-looking perspective, the book aims to accelerate the development of precision treatments that can significantly improve patient outcomes and quality of life.
Autoimmune diseases represent a significant and complex global health burden, particularly among women, yet their underlying causes remain only partially understood. Affecting nearly every organ system, these conditions are driven by intricate interactions between genetic susceptibility, epigenetic modifications, and environmental triggers such as viral infections and toxins. With over 80 distinct autoimmune disorders identified—ranging from systemic to organ-specific—diagnosis and treatment continue to pose substantial clinical challenges. Despite progress in identifying autoantibodies and disease mechanisms, current therapies fall short of inducing long-term immune tolerance or preventing disease progression. This book offers a comprehensive exploration of the latest research into the molecular, genetic, and cellular underpinnings of autoimmune disease pathogenesis. It presents emerging therapeutic approaches grounded in advanced computational modeling, systems biology, and bioinformatics, as well as the design of novel bioactive compounds. A particular focus is placed on next-generation, nanoparticle-based drug delivery systems that promise to transform the treatment landscape by enhancing targeting specificity and minimizing systemic side effects. With in-depth coverage of Rheumatoid Arthritis (RA), Type 1 Diabetes (T1D), and Multiple Sclerosis (MS), this volume serves as a critical resource for specialists, researchers, and clinicians seeking to deepen their understanding of autoimmune disease mechanisms and therapeutic innovation. Through interdisciplinary insights and a forward-looking perspective, the book aims to accelerate the development of precision treatments that can significantly improve patient outcomes and quality of life.
| Erscheint lt. Verlag | 26.9.2025 |
|---|---|
| Zusatzinfo | VIII, 284 p. 34 illus., 25 illus. in color. |
| Sprache | englisch |
| Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Rheumatologie |
| Naturwissenschaften ► Biologie | |
| Technik | |
| Schlagworte | Animal models for drug administration • Biomarkers • Computation simulation • epigenetics • Multiple Sclerosis • nanoformulation • Rheumatoid Arthritis • Type 1 Diabetes |
| ISBN-10 | 981-95-0520-8 / 9819505208 |
| ISBN-13 | 978-981-95-0520-3 / 9789819505203 |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
PDF (Wasserzeichen)DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasserzeichen und ist damit für Sie personalisiert. Bei einer missbräuchlichen Weitergabe des eBooks an Dritte ist eine Rückverfolgung an die Quelle möglich.
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich
